Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Silver Bullet Creates Credibility

Finding credibility It is very difficult for a new issuer to find goodwill in the capital markets. Historically, and we all have a story to add to this, not every company has told the truth or, in some cases, even known what the truth was, leading to jaded hearts, apathet...
Featured Submission | January 31, 2022 |

Tired of Big Box Cannabis? Investors Should Consider the Craft Sector

The craft cannabis industry evolved in 2021 to become a major disruptor to big-box cannabis. Yet, micro-cultivators still face hurdles to get their product to market as demand from younger consumers increases. Solutions are needed. One company at the forefront of this chang...
Jocelyn Aspa | November 25, 2021 |

Auto industry rebound could drive these under $10 stocks

The unpopular trade I told you about one month ago – to go long homebuilding stocks – is off to a great start. The big homebuilder fund ( XHB ) is up around 8% so far, and just hit a new yearly high. Today, I have another trade most people will think is crazy, whi...
Frank Curzio | October 28, 2012 |

Biogen Shares Rebound Strongly on Updated Phase 3 Alzheimer's Data and Q3 Earnings

Shares of Biogen Inc. opened nearly 39% higher today after the firm announced plans to submit a Biologics License Application to the FDA in early 2020 for its Alzheimer's drug aducanumab based on new analysis of larger datasets from two phase 3 studies. The company also anno...
Streetwise Reports | October 23, 2019 |

Applied Therapeutics Investors Like the ACTION in Phase 2 Galactosemia Study

Applied Therapeutics' shares traded 25% higher today after the company reported positive topline results from its Pivotal Phase 2 ACTION Study of AT-007 for use in the treatment of galactosemia. The firm expects to file for regulatory approval of AT-007 in H2/20. This...
Streetwise Reports | January 9, 2020 |

Buzz on the Bullboards: Volatility persists in the face of economic indicators

This week has proven to be a challenging one for investors on both sides of the border. Canada’s main stock index struggled to gain traction as Statistics Canada reported another rise in the Industrial Product Price Index for April, reflecting ongoing...
Jonathon Brown | May 30, 2024 |

Voxtur is the Leading Provider of Digital, SaaS Solutions for Real Estate Transactions in N. America

Before we dive into what makes Voxtur Analytics ( TSX-V: VXTR ; OTCQB: VXTRF) a standout PropTech company (and an undervalued investment opportunity), it’s worth highlighting a few recent developments: –Voxtur has seen revenues increase 300% year-over-year a...
Stockhouse Editorial | September 22, 2021 |

A Company on a Mission to Revolutionize Mental Healthcare. Here’s How.

When Stockhouse Editorial last caught up with Cybin Inc. ( NEO.CYBN , NYSE: CYBIN , Forum ) back in October, our audience learned about a leading biotechnology company focused on researching and progressing psychedelic therapeutics by utilizing proprietary drug discover...
Dave Jackson | January 31, 2022 |

Oncology Vaccine Developer's Lead Programs 'On Track or Better'

The biopharma's two assets are discussed and Q1/19 financial results are provided in a BTIG research report. In a May 13 research note, BTIG analyst Thomas Shrader reported that Gritstone Oncology Inc.'s (GRTS:NASDAQ) lead clinical programs, GRANITE and SL...
Streetwise Reports | May 27, 2019 |

Calculate the Trading Strategies' Profitability like a Pro

Investors venture into cryptocurrency trading to gain profits. They employ customized trading strategies, portfolio management strategies, and progressive investment decisions throughout their trade. Due to the progressive nature of trading, tracking one&CloseCurlyQuote...
Julia Beyers | September 5, 2019 |
1 2 3 4 5 6 7 8 9